Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Tech World.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on June 2, 2025
Global Geospatial Analytics AI Market Set For 31.0% Growth, Reaching $0.42 Billion By 2029
EIN Presswire
·
June 2, 2025
The Business Research Company’s Geospatial Analytics AI Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The geospatial analytics AI market has grown …
Exploring the Growth of the Primary Immunodeficiency Disorders Global Market: A Forecast through 2025
EIN Presswire
·
June 2, 2025
The Business Research Company's Primary Immunodeficiency Disorders Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The Business Research Company’s …
Product Launch Software Market 2025: Rise In Digital Marketing Due To Increasing Mobile Adoption & AI-Powered Automation
EIN Presswire
·
June 2, 2025
The Business Research Company's Product Launch Software Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …
Comprehensive Insights of the Global Inspection Management Software Market: Key Drivers, and Forecast for 2025-2034
EIN Presswire
·
June 2, 2025
The Business Research Company’s Inspection Management Software Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- What Is The Projected Market Size Of The …
In-Depth Analysis Of The Global K-Beauty Products Market: Key Drivers, Trends, Growth Opportunities, Forecast 2025-2034
EIN Presswire
·
June 2, 2025
The Business Research Company's K-Beauty Products Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …
The luxury yacht charter market is growing steadily, rising from $16.27B in 2024 to $17.33B in 2025 at a CAGR of 6.5%
EIN Presswire
·
June 2, 2025
The Business Research Company's Luxury Yacht Charter Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical …
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from …
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
GlobeNewswire
·
June 2, 2025
Tokyo, Japan and Cambridge, UK, 3 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner, Neurocrine Biosciences (“Neurocrine”) has dosed the first patient in its Phase 3 registrational program of NBI- …
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
GlobeNewswire
·
June 2, 2025
Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International Ltd. (NASDAQ:SELX) (“SELX” or the “Company”) announced that it received a delinquency notification letter on May 27, 2025 (the “Deficiency Letter”) from the Listing Qualifications …
Key Driver Transforming The Non-Emergency Medical Transportation Market 2025: Surge In Chronic Diseases Drives Market
EIN Presswire
·
June 2, 2025
The Business Research Company's Non-Emergency Medical Transportation Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The Business Research Company’ …
In-Depth Analysis Of The Global Pharma And Biotech Crm Software Market: Key Drivers, Trends, And Forecast 2025-2034
EIN Presswire
·
June 2, 2025
The Business Research Company's Pharma And Biotech CRM Software Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /EINPresswire.com/ -- The Business Research Company’s …
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
GlobeNewswire
·
June 2, 2025
VICTORIA, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
FansHash Empowers Global Investors with Daily Passive Income via Cloud Mining
GlobeNewswire
·
June 2, 2025
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- As Bitcoin approaches its all-time high, Fanshash’s user-friendly, maintenance-free cloud mining platform has attracted a surge of miners, gaining significant momentum. Amid the latest crypto market rally, …
Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
– CR/CRh rate of 23% in pivotal Ph 2 cohort of R/R NPM1-m AML patients – – Consistent efficacy with comparable CR/CRh rates and clinically meaningful MRD-negative responses across pre-specified subgroups, regardless of prior HSCT, prior venetoclax, or FLT3 …
MDB Capital Holdings Announces Transitions In Its Board of Directors
GlobeNewswire
·
June 2, 2025
Addison, TX, June 02, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, today announced key leadership transitions within its Board …
Quest PharmaTech Provides Corporate Update
GlobeNewswire
·
June 2, 2025
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …
SunnyMining Gains Institutional Interest as Cloud Mining Sees Accelerated Adoption
GlobeNewswire
·
June 2, 2025
Boston, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- SunnyMining's latest report shows that as the popularity of cryptocurrencies continues to rise, an increasing number of users from platforms like Coinbase and Kraken are turning to cloud mining. …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Harvard Bioscience Appoints John Duke to Board of Directors
GlobeNewswire
·
June 2, 2025
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating …